SCoV-2 Ag DetectTM

Redefining Simple. Point-of-Care Visual Read COVID-19 Test


Contact your local Chembio Representative to see if you qualify for our Detect promotion ending 12/31/21.

An FDA EUA visual read rapid test for detection diagnosis of SARS-CoV-2 Antigen in nasal swab specimens.

Performance Characteristics

  • Sensitivity - 86.67%
  • Specificity - 100%
  • Symptomatic and asymptomatic serial testing


  • Direct nasal swab to cassette format
  • Fast results in only 20 minutes
  • Easy to run with no pipetting and premeasured buffer
  • Room temperature storage


  • Generate revenue by processing results in-house
  • Visual read removes capital equipment analyzer costs
  • Nasal swab sample for increased patient comfort
  • Simplified “Go Live” with Chembio’s enhanced on site training program

Test for SARS-CoV-2 in 3 Easy Steps with SCoV-2 DetectTM*

Test for SARS-CoV-2 in 3 Easy Steps with SCoV-2 DetectTM*

Product Information*

Information Type Product Details
Time to Results 20 Minutes
Sample Nasal Swab Specimen
Reader No analyzer required; Visual Read
Storage Conditions 59° to 86°F (15° to 30°C)
Reimbursement COVID-19: 87811-QW
Method Lateral Flow

Product Downloads & Links

Ordering Information

Product # of Tests Catalog Number
SCoV-2 Detect™ 50 90-2021-8
SCoV-2 Detect™ 20 91-2021-8

*This Test has not been FDA cleared or approved but has been authorized by FDA under an EUA for use by authorized laboratories. It has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. Its emergency use is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.